In vitro and in vivo inhibition of glioblastoma and neuroblastoma with MDL101731, a novel ribonucleoside diphosphate reductase inhibitor

Cancer Research

Volumn 56, Issue 2, 1996, Pages 359-361

  Piepmeier, Joseph M ^a   Rabidou, Nicole ^a   Schold Jr , S Clifford ^b   Bitonti, Alan J ^c   Prakash, Nellikunja J ^c   Bush, Tammy L ^c  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^c Merrell Dow Research Institute   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2' DEOXY 2' FLUOROMETHYLENECYTIDINE; ENZYME INHIBITOR; RIBONUCLEOSIDE DIPHOSPHATE REDUCTASE; TEZACITABINE; UNCLASSIFIED DRUG;

ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER GROWTH; CANCER SURVIVAL; DNA SYNTHESIS; DRUG EFFECT; ENZYME ACTIVITY; ENZYME INHIBITOR COMPLEX; GLIOBLASTOMA; GROWTH INHIBITION; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; NEUROBLASTOMA; PRIORITY JOURNAL; XENOGRAFT;

EID: 0030029803     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (18)

1. Borardi, A., Silvani, A , Milanesi, I., Broggi, G., and Fariselli, L. Efficacy of 8-drugs-in-one-day combination in treatment of recurrent GBM patients. J. NeuroOncol., 12. 153-158, 1992
2. Walker, M., Green, S., Byar, D , Alexander, E., Batzdorf, U , Brooks, W., Hunt, W , MacCarty, C , Mahaley, S., Mealey, J., Owens, G., Ransohoff, J., Robertson, J., Shapiro, W., Smith, K., Wilson, C., and Strike, T. Randomized comparisons of radiotherapy and nitrosoureas for the treatment of malignant gliomas after surgery. N. Engl J Med., 303. 1323-1329, 1980.
3. Chang, C., Horton, J., Schoenfeld, D., Salazar, O , Perez-Tamayo, R., Kramer, S., Weinstein, A., Nelson, J., and Tsukada, Y Comparison of postoperative radiotherapy and combined postoperative radiotherapy and chemotherapy in the multidisciplinary management of malignant gliomas. Cancer (Phila.), 52: 997-1007, 1983.
4. McCarthy, J., Matthews, D., Stemerick, D., Huber, E., Bey, P , Lippert, B., Snyder, R., and Sunkara, P Stereospecific method to E and Z terminal fluoro olefins and its application to the synthesis of 2′-deoxy-2′-fluoromethylene nucleosides as potential inhibitors of ribonucleoside diphosphate reductase. J. Am. Chem. Soc., 113: 7439-7440, 1990.
5. Bitonti, A , Dumont, J , Bush, T., Cashman, E., Cross-Doersen, D., Wright, P , Matthews, J., McCarthy, J , and Kaplan, D Regression of human breast tumor xenografts in response to (E)-2′-(fluoromethylene)cytidine, an inhibitor of ribonucleoside diphosphate reductase. Cancer Res., 54: 1485-1490, 1994.
6. Bitonti, A , Bush, T., Lewis, M., and Sunkara, P. Response of human colon and prostate tumor xenografts to (E)-2′-(fluoromethylene) cytidine, an inhibitor of ribonucleotide reductase. Anticancer Res., 15: 1-4, 1995.
7. Elford, H., Freese, M., Passamani, E., and Morris, H Ribonucleotide reductase and cell proliferation. J. Biol Chem., 245: 5228-5233, 1970
8. Elford, H. Effect of hydroxyurea on ribonucleoside reductase. Biochem. Biophys. Res. Commun , 33: 129-135, 1968.
9. Carmichael, J., Philip, P., Rea, D., Kerr, H., Walling, J., Harris, A., and Possinger, K. Gemcitabine: an active drug in advanced breast cancer. Results of a phase II study. Proc. Am. Clin Oncol., 11: 136, 1992.
10. Piepmeier, J., Keefe, D., Weinstein, M , Yoshida, D., Zielinski, J., Lin, T., Chen, Z , and Naftolin, F. Estramustine and related analogs rapidly and reversibly inhibit DNA synthesis and alter morphology in human glioblastoma cells. Neurosurgery (Baltimore), 32. 422-431, 1993
11. Giard, D , Aaronson, S , and Todaro, G. In vitro cultivation of human tumors: establishment of cell lines derived from a series of solid tumors. J. Natl. Cancer Inst., 51. 1417-1423, 1973.
12. Bullard, D , Schold, C , and Bigner, S Growth and chemotherapeutic response in athymic mice of tumors arising from human glioma-derived cell lines. J. Neuropathol. & Exp. Neurol., 40: 410-427, 1981.
13. Tishler, R , Geard, C., Hall, E., and Schiff, P. Taxol sensitizes human astrocytoma cells to radiation. Cancer Res., 52. 3495-3497, 1992.
14. Yoshida, D., Piepmeier, J., and Weinstein, M Estramustine sensitizes human glioblastoma cells to irradiation. Cancer Res., 54: 1415-1417, 1994.
15. 6-benzylguanine and 1,3-bis(2-chloroethyl)-1-nitrosourea Cancer Chemother. Pharmacol., 32: 471-476, 1993
16. Levin, V. Pharmacokinetics and CNS chemotherapy. In. K. Hellman and S. Carter (eds.), Fundamentals of Cancer Chemotherapy, p. 28. New York: McGraw-Hill, Inc., 1986
17. Schold, C , Friedman, H., and Bigner, D. Therapeutic profile of human glioma line D54MG in athymic mice Cancer Treat Rep , 71 849-850, 1987.
18. Jordan, J., Hand, C , Markowitz, R , and Black, P. Test for chemotherapeutic sensitivity of cerebral gliomas: use of calorimetric MTT assay J. Neuro-Oncol., 14: 19-35, 1992.